Home

Tiède Rituel confirmer vas ceo novartis En bonne santé Je suis désolé devise

Novartis on LinkedIn: Today we announced appointment of Vasant (Vas)  Narasimhan, M.D., Global… | 281 comments
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments

Quand Novartis séduit plus que Roche - Le Temps
Quand Novartis séduit plus que Roche - Le Temps

Novartis CEO Narasimhan aims to surmount $9B patent cliff with 20  blockbuster launches | Fierce Pharma
Novartis CEO Narasimhan aims to surmount $9B patent cliff with 20 blockbuster launches | Fierce Pharma

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

Vas Narasimhan - Novartis | LinkedIn
Vas Narasimhan - Novartis | LinkedIn

Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery |  Fortune
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company -  YouTube
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

Bâle est très ouvert aux nouveaux arrivants - Basel Area Business &  Innovation
Bâle est très ouvert aux nouveaux arrivants - Basel Area Business & Innovation

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

Novartis CEO sees 'better place' with Covid by year-end | Mint
Novartis CEO sees 'better place' with Covid by year-end | Mint

Novartis CEO on how yoga & lessons from his grandparents help him take big  professional decisions
Novartis CEO on how yoga & lessons from his grandparents help him take big professional decisions

Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Novartis CEO says preparedness for a new pandemic has not improved
Novartis CEO says preparedness for a new pandemic has not improved

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on  sales | Fierce Pharma
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma

Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT |  Fierce Pharma
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma

Novartis CEO explains how AI will impact drug development
Novartis CEO explains how AI will impact drug development

Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint

Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint

Les jours de Vas Narasimhan à la tête de Novartis seraient comptés |  Agefi.com
Les jours de Vas Narasimhan à la tête de Novartis seraient comptés | Agefi.com

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

Novartis faces a new crisis. For CEO Vas Narasimhan, this time is different
Novartis faces a new crisis. For CEO Vas Narasimhan, this time is different

Performance slump takes toll on Novartis' CEO's 2022 payout
Performance slump takes toll on Novartis' CEO's 2022 payout

Vasant Narasimhan | Novartis
Vasant Narasimhan | Novartis

Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D.,  Global Head of Drug Development and Chief Medical Officer, as the new CEO  of Novartis, effective February 1, 2018. We thank
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank